Nuclera invites you to their event

Gene to Grid in Four Days: Cell-Free GPCRs for Cryo-EM

About this event

For GPCRs, obtaining a high-resolution cryo-EM structure can be challenging long before a sample reaches the microscope. This is particularly true for apo and antagonist-bound receptors, where their small size, conformational flexibility and absence of a stabilizing G-protein complex can make structural characterization difficult.

Join Dr Dima Chirgadze (University of Cambridge) and Dr Thomas Guilliam (Nuclera) as they explore how a collaborative study brought together cell-free protein synthesis and cryo-EM to address these challenges. Discover how direct synthesis into defined lipid nanodiscs, combined with construct and membrane-condition screening using the eProtein Discovery™ system, provided a route to producing GPCRs without post-expression detergent extraction and reconstitution. The approach was also demonstrated across 12 additional GPCRs, including six orphan receptors, which were purified and assessed for protein quality.

But could this approach deliver the quality needed for high-resolution structural determination? Using antagonist-bound A₂AR as a proof of concept, Tom and Dima will reveal the critical experimental innovations that enabled the team to progress from gene assembly to vitrified cryo-EM grids in just four days, and subsequently determine a 3.38 Å structure. From protein engineering and quality control to grid preparation, imaging and reconstruction, they'll explore what made this possible and what it could mean for studying challenging GPCR conformations, particularly apo and antagonist-bound states.

Nuclera

Nuclera empowers researchers to accelerate discovery with rapid, in-house access to high-quality functional proteins.